[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FI53457C - Foerfarande foer framstaellning av saodana 2-aryl- 2-cykloalkyl- och 2-alkyl-8-azapurin-6-onderivat som laempar sig foer vaord av andningssjukdomar - Google Patents

Foerfarande foer framstaellning av saodana 2-aryl- 2-cykloalkyl- och 2-alkyl-8-azapurin-6-onderivat som laempar sig foer vaord av andningssjukdomar

Info

Publication number
FI53457C
FI53457C FI3560/71A FI356071A FI53457C FI 53457 C FI53457 C FI 53457C FI 3560/71 A FI3560/71 A FI 3560/71A FI 356071 A FI356071 A FI 356071A FI 53457 C FI53457 C FI 53457C
Authority
FI
Finland
Prior art keywords
foer
vaord
onderivat
andningssjukdomar
saodana
Prior art date
Application number
FI3560/71A
Other languages
English (en)
Finnish (fi)
Other versions
FI53457B (es
Inventor
Barbara Joyce Broughton
Bryan John Large
Stuart Malcolm Marshall
David Lord Pain
Kenneth Robert Harr Wooldridge
Original Assignee
May & Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May & Baker Ltd filed Critical May & Baker Ltd
Publication of FI53457B publication Critical patent/FI53457B/fi
Application granted granted Critical
Publication of FI53457C publication Critical patent/FI53457C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI3560/71A 1970-12-15 1971-12-14 Foerfarande foer framstaellning av saodana 2-aryl- 2-cykloalkyl- och 2-alkyl-8-azapurin-6-onderivat som laempar sig foer vaord av andningssjukdomar FI53457C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB5955670 1970-12-15
GB5955270 1970-12-15
GB4975671A GB1338235A (en) 1970-12-15 1971-10-26 Azapurinones
GB5345771 1971-11-17

Publications (2)

Publication Number Publication Date
FI53457B FI53457B (es) 1978-01-31
FI53457C true FI53457C (fi) 1978-05-10

Family

ID=27449009

Family Applications (1)

Application Number Title Priority Date Filing Date
FI3560/71A FI53457C (fi) 1970-12-15 1971-12-14 Foerfarande foer framstaellning av saodana 2-aryl- 2-cykloalkyl- och 2-alkyl-8-azapurin-6-onderivat som laempar sig foer vaord av andningssjukdomar

Country Status (25)

Country Link
US (1) US3987160A (es)
JP (1) JPS5310599B1 (es)
AR (4) AR192602A1 (es)
AT (4) AT319235B (es)
AU (1) AU458277B2 (es)
BE (1) BE776683A (es)
BG (3) BG20805A3 (es)
CH (5) CH546779A (es)
DD (1) DD95007A5 (es)
DE (1) DE2162096A1 (es)
DK (1) DK141249B (es)
FI (1) FI53457C (es)
FR (1) FR2118078B1 (es)
GB (1) GB1338235A (es)
HK (1) HK42177A (es)
HU (1) HU165079B (es)
IE (1) IE35897B1 (es)
IL (1) IL38364A (es)
IS (1) IS1099B6 (es)
LU (1) LU64457A1 (es)
NL (1) NL174943C (es)
NO (1) NO134257C (es)
OA (1) OA03930A (es)
SE (1) SE393381B (es)
ZM (1) ZM18971A1 (es)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1493685A (en) * 1970-12-15 1977-11-30 May & Baker Ltd 8-azapurinones
BE792648A (fr) * 1971-12-13 1973-06-12 May & Baker Ltd Derives de l'isoquinoleine
FR2406638A1 (fr) * 1977-10-21 1979-05-18 May & Baker Ltd Nouvelles aza-8 purinones-6, leur preparation et les compositions pharmaceutiques les contenant
EP0007727B1 (en) * 1978-07-24 1983-11-30 Beecham Group Plc Benzopyranotriazoles, preparation of these compounds and pharmaceutical composition containing them
JPS60226887A (ja) * 1984-04-25 1985-11-12 Dai Ichi Seiyaku Co Ltd トリアゾロピリミジン誘導体
CA1303037C (en) * 1987-02-02 1992-06-09 Smith Kline & French Laboratories Limited Purinone derivatives as bronchodilators vasodilators and anti-allergic agents
DE3873812D1 (de) * 1987-04-07 1992-09-24 Ciba Geigy Ag 3h-1,2,3-triazolo(4,5-d)pyrimidine.
US5204353A (en) * 1987-04-07 1993-04-20 Ciba-Geigy Corporation 3-benzyl-3H-1,2,3-triazolo[4,5-d]pyrimidines, compositions thereof, and method of treating epilepsy therewith
FR2618073B1 (fr) * 1987-07-16 1990-09-07 Pf Medicament Comprimes de type a matrice hydrophile a base de salbutamol et leur procede de preparation
GB8817651D0 (en) * 1988-07-25 1988-09-01 Smith Kline French Lab Chemical compounds
DE4211239C2 (de) * 1992-04-03 1995-11-16 Max Planck Gesellschaft Arzneimittel gegen Herz-Kreislauf-Erkrankungen
GB9213623D0 (en) * 1992-06-26 1992-08-12 Pfizer Ltd Therapeutic agents
US5734053A (en) * 1992-06-26 1998-03-31 Pfizer Inc Purinone antianginal agents
GB9311920D0 (en) 1993-06-09 1993-07-28 Pfizer Ltd Therapeutic agents
US6129930A (en) * 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US20080045573A1 (en) * 1993-09-20 2008-02-21 Bova David J Methods and Sustained Release Nicotinic Acid Compositions for Treating Hyperlipidemia
US6080428A (en) * 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US6676967B1 (en) * 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
GB9404485D0 (en) * 1994-03-09 1994-04-20 Cancer Res Campaign Tech Benzamide analogues
ATE213246T1 (de) 1997-11-12 2002-02-15 2-phenyl-substituierte imidazotriazinone als phosphodiesterase inhibitoren
DE19838705A1 (de) * 1998-08-26 2000-03-02 Bayer Ag Neue Dihydro-(1,2,3)-triazolo-[4,5-d]pyrimidin-7-one
IT1318674B1 (it) * 2000-08-08 2003-08-27 Nicox Sa Faramaci per l'incontinenza.
DE10232113A1 (de) 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
DE102005009240A1 (de) 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EA020466B1 (ru) 2007-06-04 2014-11-28 Синерджи Фармасьютикалз Инк. Агонисты гуанилатциклазы, пригодные для лечения желудочно-кишечных нарушений, воспаления, рака и других заболеваний
CA2930674A1 (en) 2008-06-04 2009-12-10 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
JP2011528375A (ja) 2008-07-16 2011-11-17 シナジー ファーマシューティカルズ インコーポレイテッド 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
WO2012118972A2 (en) 2011-03-01 2012-09-07 Synegy Pharmaceuticals Inc. Process of preparing guanylate cyclase c agonists
WO2014131024A2 (en) 2013-02-25 2014-08-28 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
JP2016514670A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド 他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト
AU2014235215A1 (en) 2013-03-15 2015-10-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
US10011637B2 (en) 2013-06-05 2018-07-03 Synergy Pharmaceuticals, Inc. Ultra-pure agonists of guanylate cyclase C, method of making and using same
US20160184387A1 (en) 2013-08-09 2016-06-30 Dominique Charmot Compounds and methods for inhibiting phosphate transport
JP2020502121A (ja) 2016-12-14 2020-01-23 レスピラ セラピューティクス インコーポレイテッドRespira Therapeutics,Inc. 肺高血圧症および他の肺障害の処置のための方法および組成物
TWI845600B (zh) 2019-01-24 2024-06-21 美商普羅米修斯生物科學股份有限公司 Gpr35調節劑
JP2022533251A (ja) 2019-05-21 2022-07-21 アルデリックス, インコーポレイテッド 患者において血清リン酸塩を低下させるための組み合わせ
AR123034A1 (es) * 2020-07-23 2022-10-26 Prometheus Biosciences Inc Agentes terapéuticos dirigidos a gpr35

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2407204A (en) * 1944-07-22 1946-09-03 American Cyanamid Co Triazolo (d) pyrimidines and methods of preparing the same
US2993039A (en) * 1959-11-06 1961-07-18 Upjohn Co Preparing nu-glycosides of aldose and ketose sugars

Also Published As

Publication number Publication date
FI53457B (es) 1978-01-31
ZM18971A1 (en) 1972-08-21
HK42177A (en) 1977-08-19
DK141249C (es) 1980-08-04
CH546779A (fr) 1974-03-15
AR192602A1 (es) 1973-02-28
DD95007A5 (es) 1973-01-12
SE393381B (sv) 1977-05-09
HU165079B (es) 1974-06-28
JPS5310599B1 (es) 1978-04-14
GB1338235A (en) 1973-11-21
NL174943B (nl) 1984-04-02
NL7117142A (es) 1972-06-19
AT315839B (de) 1974-06-10
IL38364A (en) 1975-08-31
NO134257C (es) 1976-09-08
AR199467A1 (es) 1974-09-09
LU64457A1 (es) 1972-08-23
FR2118078B1 (es) 1975-08-01
AR192689A1 (es) 1973-02-28
CH555351A (fr) 1974-10-31
IL38364A0 (en) 1972-02-29
AU3686771A (en) 1973-06-21
AT317211B (de) 1974-08-26
FR2118078A1 (es) 1972-07-28
IE35897B1 (en) 1976-06-23
NO134257B (es) 1976-05-31
CH550814A (fr) 1974-06-28
IS2047A7 (is) 1972-06-16
AT319235B (de) 1974-12-10
CH556860A (de) 1974-12-13
DE2162096C2 (es) 1988-02-11
US3987160A (en) 1976-10-19
BG20805A3 (bg) 1975-12-20
AR199468A1 (es) 1974-09-09
BE776683A (fr) 1972-06-14
CH552610A (fr) 1974-08-15
IS1099B6 (is) 1982-11-18
BG20806A3 (bg) 1975-12-20
AU458277B2 (en) 1975-02-20
NL174943C (nl) 1984-09-03
IE35897L (en) 1972-06-15
BG20807A3 (bg) 1975-12-20
DE2162096A1 (de) 1972-07-06
DK141249B (da) 1980-02-11
OA03930A (fr) 1975-08-14
AT315838B (de) 1974-06-10

Similar Documents

Publication Publication Date Title
FI53457C (fi) Foerfarande foer framstaellning av saodana 2-aryl- 2-cykloalkyl- och 2-alkyl-8-azapurin-6-onderivat som laempar sig foer vaord av andningssjukdomar
FI54057C (fi) Foerfarande foer framstaellning av en skumdaemparkomposition
FI54139C (fi) Foerfarande foer katalytisk krackning av bensin
FI54345C (fi) Foerfarande foer framstaellning av cellulosamassa
FI54032C (fi) Normeringsfoerfarande foer maetningsanordning foer bestaemning av kvadrat metervikt
FI54854B (fi) Foerfarande foer framstaellning av en roekprodukt
FI53903C (fi) Kopplingsplint foer skruvfri anslutning av isolerade ledare
FI54586B (fi) Foerfarande foer avlaegsnande av kvicksilver fraon en klorhaltg avfallssaltloesning fraon en kvicksilvercell
FI54550C (fi) Foerfarande foer framstaellning av margarinfett
FI53825C (fi) Framstaellning av etylenpropylenkopolymer med trifenylfosfit som katalysatorhjaelpmedel
FI53297C (fi) Foerfarande att upparbeta avfallsvatten som innehaoller kvicksilverfoeroreningar
FI54482B (fi) Foerfarande foer framstaellning av bronkolytiskt aktiva teofyllinderivat
FI53521C (fi) Roekdetektor foer optisk detektering av foerbraenningsalstrade aerosoler
FI54350B (fi) Foerfarande foer oxidering av svartlut
FI53839C (fi) Foerfarande foer kalkning av djurskinn eller -hudar
FI54246B (fi) Anordning foer att bilda en foeretraedesvis kemiskt reaktionsbenaegen blandning av konstaemneskomponenter
FI54405B (fi) Anlaeggning foer kylning av aonga
FI53842B (fi) Foerfarande foer framstaellning av fiberprodukter
FI53304C (fi) Foerfarande foer framstaellning av des-fenylalanin b1-insulin
FI53450C (fi) Foerfarande foer framstaellning av optiskt aktiva bicykliska foereningar
FI54321B (fi) Foerfarande foer framstaellning av foerbaettrade vaederbestaendiga titandioxidpigment
FI54303C (fi) Nytt foerfarande foer framstaellning av metyl-1-naftylditiocarbaminsyra-2-benzoxazolylester
FI54219B (fi) Anvaendning av substituerade fenyltiokarbamater foer selektiv bekaempning av ograes
FI46554B (fi) Utnyttjande av foerbraenningsmotors avgasfilter som vaermeapparat
FI55397C (fi) Spaennbult, saerskilt foer uppbaerande av radiatorer